对比增强数字乳腺断层摄影与乳腺磁共振监测新辅助化疗反应的患者耐受性与偏好
前瞻性先导研究纳入18例患者,在化疗前及疗程结束后分别完成对比增强数字乳腺断层摄影(CE-DBT)与乳腺磁共振(MRI)体验问卷。77%的情况下患者偏好CE-DBT,总体体验、非乳腺疼痛、焦虑及被工作人员安抚感均优于MRI,但CE-DBT期间乳腺疼痛更明显。
要点
- 77%的情况下患者偏好CE-DBT,化疗前与疗程结束后无差异。
- CE-DBT的总体体验、非乳腺疼痛、焦虑及被安抚感均优于MRI。
- CE-DBT期间乳腺疼痛较MRI更明显,尽管乳腺压迫时间相对较长。
核心结论
- 患者偏好CE-DBT优于MRI,为对比增强乳腺摄影技术提供了进一步证据;尽管乳腺压迫时间相对较长,患者总体仍偏好CE-DBT。
研究设计与样本
- 前瞻性先导研究,18例患者纳入;在化疗前及疗程结束后影像检查后完成CE-DBT与MRI问卷;统计采用Wilcoxon符号秩检验与McNemar检验(SPSS v.25)。
临床应用与阅片要点
- 作者认为患者偏好CE-DBT优于MRI,为对比增强乳腺摄影技术提供了进一步证据。
- 作者指出对比增强乳腺摄影技术提供了可替代乳腺MRI、更易获得的影像技术。
- 原文指出本研究是首个在新辅助化疗背景下直接探讨患者对CE-DBT与MRI偏好的研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Contrast-enhanced digital breast tomosynthesis (CE-DBT) is a novel imaging technique, combining contrast-enhanced spectral mammography and tomosynthesis. This may offer an alternative imaging technique to breast MRI for monitoring of response to neoadjuvant chemotherapy. This paper addresses patient experience and preference regarding the two techniques.
METHODS: Conducted as part of a prospective pilot study; patients were asked to complete questionnaires pertaining to their experience of CE-DBT and MRI following pre-treatment and end-of-treatment imaging. Questionnaires consisted of eight questions answered on a categorical scale, two using a visual analogue scale (VAS), and a question to indicate preference of imaging technique. Statistical analysis was performed with Wilcoxon signed rank test and McNemar test for related samples using SPSS v. 25.
RESULTS: 18 patients were enrolled in the pilot study. Matched CE-DBT and MRI questionnaires were completed after 22 patient episodes. Patient preference was indicated after 31 patient episodes. Overall, on 77% of occasions patients preferred CE-DBT with no difference between pre-treatment and end-of-treatment imaging. Overall experience (p = 0.008), non-breast pain (p = 0.046), anxiety measured using VAS (p = 0.003), and feeling of being put at ease by staff (p = 0.023) was better for CE-DBT. However, more breast pain was experienced during CE-DBT when measured on both VAS (p = 0.011) and categorical scale (p = 0.021).
CONCLUSION: Our paper suggests that patients prefer CE-DBT to MRI, adding further evidence in favour of contrast-enhanced mammographic techniques.
ADVANCES IN KNOWLEDGE: Contrast mammographic techniques offer an alternative, more accessible imaging technique to breast MRI. Whilst other studies have addressed patient experience of contrast-enhanced spectral mammography, this is the first study to directly explore patient preference for CE-DBT over MRI in the setting of neoadjuvant chemotherapy, finding that overall, patients preferred CE-DBT despite the relatively long breast compression.
引用
- Savaridas, Whelehan, Warwick, et al. Contrast-enhanced digital breast tomosythesis and breast MRI to monitor response to neoadjuvant chemotherapy: patient tolerance and preference. Br J Radiol. 2022. PMID: 35143334. doi:10.1259/bjr.20210779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。